ATP Citrate Lyase is a General Tumour Biomarker and Contributes to the Development of Cutaneous Squamous Cell Carcinoma
ATP citrate lyase, the first rate-limiting enzyme in de novo lipogenesis, plays a crucial role in tumour progression. This study explores ATP citrate lyase’s potential as a tumour biomarker and its role in cutaneous squamous cell carcinoma. ATP citrate lyase expression patterns were analysed using T...
Main Authors: | Ruiting Luo, Yingjian Huang, Ruimin Bai, Meng Liu, Liang Sun, Xiaofei Wang, Yan Zheng |
---|---|
Format: | Article |
Language: | English |
Published: |
Medical Journals Sweden
2024-04-01
|
Series: | Acta Dermato-Venereologica |
Subjects: | |
Online Access: | https://medicaljournalssweden.se/actadv/article/view/23805 |
Similar Items
-
Exploring the Role of ATP-Citrate Lyase in the Immune System
by: Monica Dominguez, et al.
Published: (2021-02-01) -
Myeloid ATP Citrate Lyase Regulates Macrophage Inflammatory Responses In Vitro Without Altering Inflammatory Disease Outcomes
by: Sanne G. S. Verberk, et al.
Published: (2021-04-01) -
Polarization of Human Macrophages by Interleukin-4 Does Not Require ATP-Citrate Lyase
by: Dmitry Namgaladze, et al.
Published: (2018-12-01) -
ATP-citrate lyase B (ACLB) negatively affects cell death and resistance to Verticillium wilt
by: Fujie Liu, et al.
Published: (2022-09-01) -
Impact of ATP-citrate lyase catalytic activity and serine 455 phosphorylation on histone acetylation and inflammatory responses in human monocytic THP-1 cells
by: Monica Dominguez, et al.
Published: (2022-11-01)